Saturday 17 October 2026 Export AUPH’s income statement to Excel — free account

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc’s revenue for fiscal 2025 (year ended December 2025) was $283.1 million, up 20.4% from fiscal 2024. In the quarter to June 2026, revenue grew 18.9%, EPS grew 81.3%, free cash flow grew 19.1% and total debt fell 25.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

16.51 0.22 −1.32%

Follow AUPH

Alert me

Market cap: $2.2B
P/E: 6.9×
Fwd P/E: 16.5×
Dividend yield: —
F-score: 8/9
Altman Z: 7.86
Beneish M: −0.88
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	19.05	7.35	6.56	7.10
P/S ratio Full definition →		5.48	7.57	6.58	7.09
P/FCF ratio Full definition →		12.15	15.83	11.77	12.61
P/Operating CF Full definition →		32.77	46.93	60.25	41.99
P/B ratio Full definition →		3.98	3.69	3.46	3.59
Price to Tangible BV Full definition →		4.02	3.71	3.48	3.61
EV/Sales Full definition →		4.37	6.35	5.47	5.81
EV/EBITDA Full definition →		11.66	13.42	10.93	11.30
EV/Operating CF Full definition →		9.66	13.25	9.77	10.32
EV/FCF Full definition →		9.68	13.27	9.79	10.33
Quick Ratio Full definition →		5.02	4.69	4.94	4.85
Current Ratio Full definition →		5.76	5.25	5.55	5.42
Net Debt/EBITDA Full definition →		(8.33)	(10.47)	(7.11)	(8.88)
Debt/Assets Full definition →		10.56%	6.96%	6.65%	5.55%
Debt/Equity Full definition →		0.15	0.09	0.08	0.07
Asset Turnover Full definition →		0.49	0.43	0.49	0.48
Operating CF/Net income Full definition →		1.41	0.22	0.95	1.41
Capex/Depreciation Full definition →		(0.01)	(0.01)	(0.01)	0.00
Interest Coverage Full definition →		27.91	26.90	41.21	42.31
Research and Development Expense of Revenue Full definition →		11.48%	14.13%	9.61%	15.68%
Selling, General and Administrative Expense of Revenue Full definition →		35.64%	37.94%	28.35%	28.25%
Intangible Assets out of Total Assets Full definition →		0.01	0.01	0.01	0.00
Share Based Compensation of Revenue Full definition →		8.06%	8.72%	(1.11%)	3.41%
Graham Net Nets Full definition →		0.19	0.15	0.17	0.16
Graham Number Full definition →		6.02	14.53	14.77	15.94
Earnings Yield Full definition →		5.25%	13.61%	15.25%	14.08%
Free Cash Flow Yield Full definition →		8.23%	6.32%	8.49%	7.93%
Revenue per Share Full definition →		0.56	0.57	0.59	0.64
Operating CF per Share Full definition →		0.34	0.34	0.25	0.40
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.34	0.34	0.25	0.40
Cash per Share Full definition →		2.67	2.96	2.86	3.41
Shareholders Equity per Share Full definition →		2.78	4.33	4.29	4.73
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		2.78	4.33	4.29	4.73
Free Cash Flow Full definition →		44.38	45.60	32.52	52.57
Working Capital Full definition →		362.52	398.24	393.69	441.43
Capital Expenditures Full definition →		(0.06)	(0.07)	(0.04)	0.00
Net Current Asset Value Full definition →		276.98	321.71	323.87	363.93
EV/EBIT Full definition →		14.49	15.71	12.56	12.86
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		18.18	18.73	15.11	15.70
Other line items
Average Receivables Full definition →		33.61	39.00	44.76	40.61
Average Payables Full definition →		29.49	4.25	3.44	2.52
Average Inventory Full definition →		41.75	42.46	46.30	45.83
Average Assets Full definition →		538.44	651.12	614.42	647.41
Average Common Equity Full definition →		376.89	479.40	458.91	475.08

Show all line items

Columns are period end dates

Stockrow Weekly